Tweet
Brazil -
Translation Google
São Paulo investigates suspected Ebola case in 37-year-old man.
The patient had been in the Democratic Republic of Congo, an outbreak zone.
Guilherme Jeronymo - Reporter for Agência Brasil
Published on 05/30/2026 - 1:57 PM
São Paulo
A 37-year-old man with symptoms consistent with Ebola is hospitalized at the Emílio Ribas Institute of Infectious Diseases in São Paulo. The results to confirm or rule out the diagnosis are still pending.
According to information from the São Paulo State Health Department (SES), the case of the patient, a native of the Democratic Republic of Congo, was registered this Saturday. He recently traveled to his country of origin and presented symptoms of the disease, such as a high fever.
The country is experiencing an outbreak of the disease , classified by the World Health Organization as being of international concern. There is no information about the patient's itinerary or even the date of their trip.
Given the symptoms consistent with the definition of a suspected case of viral hemorrhagic fever, the measures foreseen in the National Contingency Plan were adopted, including isolation of the patient and initiation of epidemiological and laboratory investigation.
According to a statement from the Ministry of Health, before being transferred to Emílio Ribas Hospital, the patient was treated at an Emergency Care Unit (UPA), where he presented with a high fever and inconclusive malaria tests. He arrived at the referral unit in serious condition, with diarrhea, disorientation, and rapid clinical deterioration, requiring intubation.
According to the state secretariat, the analysis of the suspected case is carried out by the Disease Control Coordination (CCD) and the Epidemiological Surveillance Center (CVE-SP).
Regiane de Paula, the Health Coordinator at the Disease Control Coordination Office of the São Paulo State Health Department, emphasizes that this is a case under investigation.
"The measures outlined were adopted based on the identification of clinical and epidemiological criteria. The procedure includes isolation, immediate notification, laboratory investigation, and monitoring in accordance with current protocols."
Protocol
In the state of São Paulo, suspected cases must be immediately reported to the municipal epidemiological surveillance and the CVE (Center for Epidemiological Surveillance). The Emílio Ribas Institute of Infectology is the state reference unit for the care of suspected or confirmed cases, and the Adolfo Lutz Institute is responsible for laboratory investigation and differential diagnosis.
In a statement, the secretary also said that she assesses the risk of the disease being introduced into Brazil and South America as very low.
"Among the factors considered are the historical absence of autochthonous transmission in the South American continent, the lack of direct flights between the affected region and South America, and the way the disease is transmitted, which requires direct contact with blood, secretions, bodily fluids, or tissues of symptomatic infected individuals."
The disease is only transmitted after the onset of symptoms, which include high fever, severe headache, muscle aches, fatigue, nausea, vomiting, diarrhea, and abdominal pain.
In severe cases, it can progress to hemorrhagic manifestations, shock, and multiple organ failure. The incubation period ranges from two to 21 days. Transmission occurs through bodily fluids.
According to the SES (State Health Secretariat), there are no licensed vaccines or specific therapies approved for the Bundibugyo strain, responsible for the current outbreak. The available vaccines and treatments were developed for the Zaire strain and have no proven efficacy against this variant.
This week, the WHO announced that there are treatments and vaccines being tested against the disease.
In a statement, the Ministry of Health said that it is continuously monitoring the international epidemiological situation and reinforcing its guidance to health services throughout the country for the early identification and appropriate management of suspected cases.
Article updated at 4:55 PM.
---------------------------------------------------------------------------------------------
São Paulo is investigating a suspected case of Ebola and maintaining health surveillance in the state.
The patient is in isolation at the Emílio Ribas Institute of Infectious Diseases, a state-run referral center for suspected cases.
Published in 30/05/2026 - 11:38
The São Paulo State Health Department is investigating a suspected case of Ebola virus disease, registered this Saturday (30), in the city of São Paulo. The analysis is being carried out by the Disease Control Coordination (CCD) and the Epidemiological Surveillance Center (CVE-SP). The patient, a 37-year-old man, from the Democratic Republic of Congo, a country with areas of disease transmission, and who recently traveled to the territory, presented symptoms such as fever, fulfilling the definition of a suspected case.
He is hospitalized in isolation at the Emílio Ribas Institute of Infectology, a state-run referral unit for the care of suspected or confirmed cases, following the established biosafety protocols. To date, there is no laboratory confirmation of the disease.
The investigation was initiated preventively after the identification of clinical and epidemiological criteria consistent with a suspected case, in accordance with national and state protocols.
“This is a suspected case under investigation. The planned measures were adopted based on the identification of clinical and epidemiological criteria. The procedure includes isolation, immediate notification, laboratory investigation, and monitoring according to current protocols,” says Regiane de Paula, Health Coordinator at the Disease Control Coordination Office of the SES-SP (São Paulo State Health Department).
Last week, the State Disease Control Coordination updated Information Note No. 01/2026, prepared in conjunction with CVE-SP and the Adolfo Lutz Institute (IAL), with guidelines for the health network regarding the outbreak of Ebola virus disease, Bundibugyo strain, currently underway in the Democratic Republic of Congo. The document reinforces surveillance measures, case definition, immediate notification, isolation, initial management, care flows, and laboratory investigation in the state.
In the state of São Paulo, suspected cases must be immediately reported to the municipal epidemiological surveillance and the CVE (Center for Epidemiological Surveillance). The Emílio Ribas Institute of Infectology is the state reference unit for the care of suspected or confirmed cases, having acted in 2014 during the Public Health Emergency of International Concern. At that time, the institute received and monitored three suspected cases, which were later ruled out. The Adolfo Lutz Institute is responsible for laboratory investigation and differential diagnosis.
The technical assessment by SES-SP indicates that the risk of the disease being introduced into Brazil and South America remains very low. Among the factors considered are the historical absence of autochthonous transmission in the South American continent, the lack of direct flights between the affected region and South America, and the disease's transmission method, which requires direct contact with blood, secretions, bodily fluids, or tissues of symptomatic infected individuals.
Even with the low risk, the recommendation is for health services to remain vigilant with people who have a fever and a history of travel, within the last 21 days, to areas with circulation of the virus. Cases of direct contact with bodily fluids of suspected or confirmed cases should also be evaluated.
Symptoms and care
Ebola virus disease can begin suddenly, with high fever, intense headache, muscle aches, fatigue, nausea, vomiting, diarrhea, and abdominal pain. In severe cases, it can progress to hemorrhagic manifestations, shock, and multiple organ failure. The incubation period ranges from two to 21 days.
The São Paulo State Health Department (SES-SP) also emphasizes that Ebola transmission does not occur before the onset of symptoms. The greatest risk is associated with direct contact with bodily fluids of infected individuals, especially in the later stages of the disease. Asymptomatic individuals with exposure considered at risk should be monitored daily for 21 days.
To date, there are no licensed vaccines or specific therapies approved for the Bundibugyo strain. The vaccines and treatments available were developed for the Zaire strain and have not been proven effective against the variant related to the current outbreak.
Notification of suspected cases
Suspected cases should be reported immediately to the Epidemiological Surveillance Center at CIEVS. The complete Information Note is available here .
Translation Google
São Paulo investigates suspected Ebola case in 37-year-old man.
The patient had been in the Democratic Republic of Congo, an outbreak zone.
Guilherme Jeronymo - Reporter for Agência Brasil
Published on 05/30/2026 - 1:57 PM
São Paulo
A 37-year-old man with symptoms consistent with Ebola is hospitalized at the Emílio Ribas Institute of Infectious Diseases in São Paulo. The results to confirm or rule out the diagnosis are still pending.
According to information from the São Paulo State Health Department (SES), the case of the patient, a native of the Democratic Republic of Congo, was registered this Saturday. He recently traveled to his country of origin and presented symptoms of the disease, such as a high fever.
The country is experiencing an outbreak of the disease , classified by the World Health Organization as being of international concern. There is no information about the patient's itinerary or even the date of their trip.
Given the symptoms consistent with the definition of a suspected case of viral hemorrhagic fever, the measures foreseen in the National Contingency Plan were adopted, including isolation of the patient and initiation of epidemiological and laboratory investigation.
According to a statement from the Ministry of Health, before being transferred to Emílio Ribas Hospital, the patient was treated at an Emergency Care Unit (UPA), where he presented with a high fever and inconclusive malaria tests. He arrived at the referral unit in serious condition, with diarrhea, disorientation, and rapid clinical deterioration, requiring intubation.
According to the state secretariat, the analysis of the suspected case is carried out by the Disease Control Coordination (CCD) and the Epidemiological Surveillance Center (CVE-SP).
Regiane de Paula, the Health Coordinator at the Disease Control Coordination Office of the São Paulo State Health Department, emphasizes that this is a case under investigation.
"The measures outlined were adopted based on the identification of clinical and epidemiological criteria. The procedure includes isolation, immediate notification, laboratory investigation, and monitoring in accordance with current protocols."
Protocol
In the state of São Paulo, suspected cases must be immediately reported to the municipal epidemiological surveillance and the CVE (Center for Epidemiological Surveillance). The Emílio Ribas Institute of Infectology is the state reference unit for the care of suspected or confirmed cases, and the Adolfo Lutz Institute is responsible for laboratory investigation and differential diagnosis.
In a statement, the secretary also said that she assesses the risk of the disease being introduced into Brazil and South America as very low.
"Among the factors considered are the historical absence of autochthonous transmission in the South American continent, the lack of direct flights between the affected region and South America, and the way the disease is transmitted, which requires direct contact with blood, secretions, bodily fluids, or tissues of symptomatic infected individuals."
The disease is only transmitted after the onset of symptoms, which include high fever, severe headache, muscle aches, fatigue, nausea, vomiting, diarrhea, and abdominal pain.
In severe cases, it can progress to hemorrhagic manifestations, shock, and multiple organ failure. The incubation period ranges from two to 21 days. Transmission occurs through bodily fluids.
According to the SES (State Health Secretariat), there are no licensed vaccines or specific therapies approved for the Bundibugyo strain, responsible for the current outbreak. The available vaccines and treatments were developed for the Zaire strain and have no proven efficacy against this variant.
This week, the WHO announced that there are treatments and vaccines being tested against the disease.
In a statement, the Ministry of Health said that it is continuously monitoring the international epidemiological situation and reinforcing its guidance to health services throughout the country for the early identification and appropriate management of suspected cases.
Article updated at 4:55 PM.
---------------------------------------------------------------------------------------------
São Paulo is investigating a suspected case of Ebola and maintaining health surveillance in the state.
The patient is in isolation at the Emílio Ribas Institute of Infectious Diseases, a state-run referral center for suspected cases.
Published in 30/05/2026 - 11:38
The São Paulo State Health Department is investigating a suspected case of Ebola virus disease, registered this Saturday (30), in the city of São Paulo. The analysis is being carried out by the Disease Control Coordination (CCD) and the Epidemiological Surveillance Center (CVE-SP). The patient, a 37-year-old man, from the Democratic Republic of Congo, a country with areas of disease transmission, and who recently traveled to the territory, presented symptoms such as fever, fulfilling the definition of a suspected case.
He is hospitalized in isolation at the Emílio Ribas Institute of Infectology, a state-run referral unit for the care of suspected or confirmed cases, following the established biosafety protocols. To date, there is no laboratory confirmation of the disease.
The investigation was initiated preventively after the identification of clinical and epidemiological criteria consistent with a suspected case, in accordance with national and state protocols.
“This is a suspected case under investigation. The planned measures were adopted based on the identification of clinical and epidemiological criteria. The procedure includes isolation, immediate notification, laboratory investigation, and monitoring according to current protocols,” says Regiane de Paula, Health Coordinator at the Disease Control Coordination Office of the SES-SP (São Paulo State Health Department).
Last week, the State Disease Control Coordination updated Information Note No. 01/2026, prepared in conjunction with CVE-SP and the Adolfo Lutz Institute (IAL), with guidelines for the health network regarding the outbreak of Ebola virus disease, Bundibugyo strain, currently underway in the Democratic Republic of Congo. The document reinforces surveillance measures, case definition, immediate notification, isolation, initial management, care flows, and laboratory investigation in the state.
In the state of São Paulo, suspected cases must be immediately reported to the municipal epidemiological surveillance and the CVE (Center for Epidemiological Surveillance). The Emílio Ribas Institute of Infectology is the state reference unit for the care of suspected or confirmed cases, having acted in 2014 during the Public Health Emergency of International Concern. At that time, the institute received and monitored three suspected cases, which were later ruled out. The Adolfo Lutz Institute is responsible for laboratory investigation and differential diagnosis.
The technical assessment by SES-SP indicates that the risk of the disease being introduced into Brazil and South America remains very low. Among the factors considered are the historical absence of autochthonous transmission in the South American continent, the lack of direct flights between the affected region and South America, and the disease's transmission method, which requires direct contact with blood, secretions, bodily fluids, or tissues of symptomatic infected individuals.
Even with the low risk, the recommendation is for health services to remain vigilant with people who have a fever and a history of travel, within the last 21 days, to areas with circulation of the virus. Cases of direct contact with bodily fluids of suspected or confirmed cases should also be evaluated.
Symptoms and care
Ebola virus disease can begin suddenly, with high fever, intense headache, muscle aches, fatigue, nausea, vomiting, diarrhea, and abdominal pain. In severe cases, it can progress to hemorrhagic manifestations, shock, and multiple organ failure. The incubation period ranges from two to 21 days.
The São Paulo State Health Department (SES-SP) also emphasizes that Ebola transmission does not occur before the onset of symptoms. The greatest risk is associated with direct contact with bodily fluids of infected individuals, especially in the later stages of the disease. Asymptomatic individuals with exposure considered at risk should be monitored daily for 21 days.
To date, there are no licensed vaccines or specific therapies approved for the Bundibugyo strain. The vaccines and treatments available were developed for the Zaire strain and have not been proven effective against the variant related to the current outbreak.
Notification of suspected cases
Suspected cases should be reported immediately to the Epidemiological Surveillance Center at CIEVS. The complete Information Note is available here .
Read more at: 
/https://i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2026/v/i/OAUiXiR7CG2rI4G4RyjA/afp-20260518-b38c7k7-v2-highres-topshotugandadrcongohealthvirusebola-1-.jpg)
Comment